The REVEAL Study

The Risk Evaluation and Education for Alzheimer’s Disease (REVEAL) Study, funded by NIH, was the first ever study to disclose APOE Alzheimer’s Disease risk to healthy patients and made important contributions to the scientific understanding of disclosing genetic risk for Alzheimer’s Disease.Through a series of multi-site randomized controlled clinical trials, REVEAL provided empirical data to address ethical, … Continued

Publications

2020

Disclosing genetic risk of Alzheimer’s dementia to individuals with mild cognitive impairment

Christensen KD, Karlawish J, Roberts JS, Uhlmann WR, Harkins K, Wood EM, Obisesan TO, Le LQ, Cupples LA, Zoltick ES, Johnson MS, Bradbury MK, Waterston LB, Chen CA, Feldman S, Perry DL, Green RC
Alzheimer's & Dementia: Translational Research & Clinical Interventions Mar 2020  

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2006

2005

2004

2003

2002

1998

1997